Moyamoya disease (MMD): clinical features
Evidence-based neurology checklist on moyamoya disease (mmd): clinical features: Demographic features The onset age is 20-79 years It usually affects young women aged 30-50 years: the mean is 42 years The highest incidence is in Japan and China The incidence is similar in American and Europe It…
Demographic features
- The onset age is 20-79 years
- It usually affects young women aged 30-50 years: the mean is 42 years
- The highest incidence is in Japan and China
- The incidence is similar in American and Europe
- It may also present in children
Presentations: ischaemic stroke: features
Presentations: ischaemic stroke: onset
Presentations: other stroke types
Presentations: movement disorders
Headache: types
References
- Kleinloog R, Regli L, Rinkel GJE, Klijn CJM. Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review. JNNP 2012; 83:531-536.
- Hallemeier CL, Rich KM, Grubb RL, et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 2006; 37:1490-1496.
- Kraemer M, Heienbrok E, Berlit P. Moyamoya disease in Europeans. Stroke 2008; 39:3193-3200.
- Liu P, Han C, Li DS, Lv XL, Li YX, Duan L. Hemorrhagic moyamoya disease in children: clinical, angiographic features, and long-term surgical outcome. Stroke 2016; 47:240-243.
- Peter Birkeland P, Hansen V, Tharmabalan V, et al. Long-term stroke risk in moyamoya disease. Int J Stroke 2023 (Online ahead of print).
- And 6 more. Subscribe to see the full list